173 related articles for article (PubMed ID: 20615397)
1. 3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulator.
Gompf HS; Greenberg JH; Aston-Jones G; Ianculescu AG; Scanlan TS; Dratman MB
Brain Res; 2010 Sep; 1351():130-140. PubMed ID: 20615397
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute microinjections of the thyroid hormone derivative 3-iodothyronamine to the preoptic region of adult male rats on sleep, thermoregulation and motor activity.
James TD; Moffett SX; Scanlan TS; Martin JV
Horm Behav; 2013 Jun; 64(1):81-8. PubMed ID: 23702093
[TBL] [Abstract][Full Text] [Related]
3. Evidence that 3,3',5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport.
Gordon JT; Kaminski DM; Rozanov CB; Dratman MB
Neuroscience; 1999; 93(3):943-54. PubMed ID: 10473259
[TBL] [Abstract][Full Text] [Related]
4. 3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line.
Sacripanti G; Lorenzini L; Bandini L; Frascarelli S; Zucchi R; Ghelardoni S
Horm Mol Biol Clin Investig; 2020 Mar; 41(1):. PubMed ID: 32114521
[TBL] [Abstract][Full Text] [Related]
5. Update on 3-iodothyronamine and its neurological and metabolic actions.
Zucchi R; Accorroni A; Chiellini G
Front Physiol; 2014; 5():402. PubMed ID: 25360120
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.
Szot P; Miguelez C; White SS; Franklin A; Sikkema C; Wilkinson CW; Ugedo L; Raskind MA
Neuroscience; 2010 Mar; 166(1):279-91. PubMed ID: 20045445
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons.
Muntoni AL; Pillolla G; Melis M; Perra S; Gessa GL; Pistis M
Eur J Neurosci; 2006 May; 23(9):2385-94. PubMed ID: 16706846
[TBL] [Abstract][Full Text] [Related]
8. 3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes.
Schanze N; Jacobi SF; Rijntjes E; Mergler S; Del Olmo M; Hoefig CS; Khajavi N; Lehmphul I; Biebermann H; Mittag J; Köhrle J
Thyroid; 2017 Jan; 27(1):11-22. PubMed ID: 27788620
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of noradrenergic beta-receptor blockade within the medial septal area on forebrain electroencephalographic and behavioral activity state in anesthetized and unanesthetized rat.
Berridge CW; Wifler K
Neuroscience; 2000; 97(3):543-52. PubMed ID: 10828536
[TBL] [Abstract][Full Text] [Related]
10. Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions.
Hoefig CS; Zucchi R; Köhrle J
Thyroid; 2016 Dec; 26(12):1656-1673. PubMed ID: 27650974
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-adrenoceptor antagonists on the firing rate of noradrenergic neurones in the locus coeruleus of the rat.
Dahlöf C; Engberg G; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):26-30. PubMed ID: 6116197
[TBL] [Abstract][Full Text] [Related]
12. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity.
Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N
Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926
[No Abstract] [Full Text] [Related]
13. Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats.
Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Wang T; Chen L; Li Q
Brain Res; 2010 Apr; 1324():64-74. PubMed ID: 20153300
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical mapping of brain triiodothyronine reveals prominent localization in central noradrenergic systems.
Rozanov CB; Dratman MB
Neuroscience; 1996 Oct; 74(3):897-915. PubMed ID: 8884785
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold.
Manni ME; De Siena G; Saba A; Marchini M; Landucci E; Gerace E; Zazzeri M; Musilli C; Pellegrini-Giampietro D; Matucci R; Zucchi R; Raimondi L
Br J Pharmacol; 2013 Jan; 168(2):354-62. PubMed ID: 22889145
[TBL] [Abstract][Full Text] [Related]
16. 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.
Dinter J; Mühlhaus J; Jacobi SF; Wienchol CL; Cöster M; Meister J; Hoefig CS; Müller A; Köhrle J; Grüters A; Krude H; Mittag J; Schöneberg T; Kleinau G; Biebermann H
J Mol Endocrinol; 2015 Jun; 54(3):205-16. PubMed ID: 25878061
[TBL] [Abstract][Full Text] [Related]
17. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
[TBL] [Abstract][Full Text] [Related]
18. Regulation of central noradrenergic activity by 5-HT(3) receptors located in the locus coeruleus of the rat.
Ortega JE; Mendiguren A; Pineda J; Meana JJ
Neuropharmacology; 2012 Jun; 62(8):2472-9. PubMed ID: 22401957
[TBL] [Abstract][Full Text] [Related]
19. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3',5'-adenosine monophosphate.
Ririe DG; Butterworth JF; Royster RL; MacGregor DA; Zaloga GP
Anesthesiology; 1995 Apr; 82(4):1004-12. PubMed ID: 7717535
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons.
West CH; Ritchie JC; Boss-Williams KA; Weiss JM
Int J Neuropsychopharmacol; 2009 Jun; 12(5):627-41. PubMed ID: 18950545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
